Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 23, 2023EBioMedicineOpen Access

Resistant and refractory migraine: clinical presentation, pathophysiology, and management

View Full Paper
Ask AI
Bookmark
Share

Authors

RORaffaele OrnelloUniversity of L'AquilaAAAnna P. AndreouKing's College LondonEMEleonora De MatteisImperial College Healthcare NHS Trust

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ornello et al. (2023) studied this question.

synapsesocial.com/papers/6a00ca5a2ff633f365781826https://doi.org/10.1016/j.ebiom.2023.104943
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention – 2022 update2022 · 458 citations
  2. 2Safety and Efficacy of 10 kHz Spinal Cord Stimulation for the Treatment of Refractory Chronic Migraine: A Prospective Long-Term Open-Label Study2021 · 21 citations
  3. 3Identifying and managing refractory migraine: barriers and opportunities?2019 · 62 citations
  4. 4European headache federation consensus on the definition of resistant and refractory migraine2020 · 272 citations